Dual chemotherapy of primary FLT3-ITD AML cells with topoisomerase inhibitors (daunorubicin, etoposide, and mitoxantrone) and AZD1208 also sensitizes cells because of accumulation of reactive oxygen species (ROS) and DNA double strand breaks [151, 152]. Here, FLT3 is linked to acute myeloid leukemia.